evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract
6039,GENE_SUMMARY,,"ARID5B, a tumor suppressor involved in transcriptional regulation, is mutated at low frequencies in a diverse range of cancers.",,2017-10-23,,84159,ARID5B,AT-rich interaction domain 5B,False,ENST00000279873,NM_032199.2,MRF-2,MRF2,DESRT,True,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
6040,GENE_BACKGROUND,,"The ARID5B (AT-rich interactive domain 5b) gene encodes a member of the AT-rich interaction domain (ARID) family of transcription factors. The ARID domain defines a highly conserved family of sequence-specific DNA-binding proteins (PMID: 8543152, 8622680) that appears to play a role in diverse biological functions including embryonic development, lymphocyte development, cell-type specific gene expression and cell growth regulation (PMID:15640446). ARID5B has been shown to be a binding partner of the demethylase, PHF2 (PMID: 21532585); the ARID5B-PHF2 complex binds to the promoters of SOX9 target genes to transcriptionally activate chondrogenesis (PMID: 24276541). Importantly, ARID5B polymorphisms confer increased risk of pediatric acute lymphoblastic leukemia (ALL) as determined by two independent genome-wide association studies (PMID: 19684604, 19684603). Both studies determined that ARID5B predisposition loci were enriched in patients with a specific subtype of ALL, named B-cell hyperdiploid ALL. It was further determined that these patients show significant association with the clinical phenotype of intracellular accumulation of methotrexate polyglutamates, which is consistent with greater sensitivity to methotrexate-based chemotherapies (PMID: 19684603, 19710713). However, it is unknown how these alleles confer greater risk of childhood ALL development.",,2017-03-22,,84159,ARID5B,AT-rich interaction domain 5B,False,ENST00000279873,NM_032199.2,MRF-2,MRF2,DESRT,True,19710713,Inherited susceptibility to pediatric acute lymphoblastic leukemia.,Nature genetics,2018-09-01T20:09:00,41,9,957-8,Levine RL,doi: 10.1038/ng0909-957,,0001-09-01,,15640446,DNA-binding properties of ARID family proteins.,Nucleic acids research,2005,33,True,66-80,Patsialou A et al,,,Patsialou A et al. Nucleic acids research. 2005;33(1)66-80.,,21532585,PKA-dependent regulation of the histone lysine demethylase complex PHF2-ARID5B.,Nature cell biology,2018-06-01T20:11:00,13,6,668-75,Baba A et al,doi: 10.1038/ncb2228,,0001-06-01,,19684603,Germline genomic variants associated with childhood acute lymphoblastic leukemia.,Nature genetics,2018-09-01T20:09:00,41,9,1001-5,Trevi√±o LR et al,doi: 10.1038/ng.432,,0001-09-01,,8543152,The immunoglobulin heavy-chain matrix-associating regions are bound by Bright: a B cell-specific trans-activator that describes a new DNA-binding protein family.,Genes &amp; development,0001-12-15,9,24,3067-82,Herrscher RF et al,,,0001-12-15,,19684604,"Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia.",Nature genetics,2018-09-01T20:09:00,41,9,1006-10,Papaemmanuil E et al,doi: 10.1038/ng.430,,0001-09-01,,24276541,Arid5b facilitates chondrogenesis by recruiting the histone demethylase Phf2 to Sox9-regulated genes.,Nature communications,2013,4,,2850,Hata K et al,doi: 10.1038/ncomms3850,,Hata K et al. Nature communications. 2013;4()2850.,,8622680,"Characterization of the dead ringer gene identifies a novel, highly conserved family of sequence-specific DNA-binding proteins.",Molecular and cellular biology,0001-03-01,16,3,792-9,Gregory SL et al,,,0001-03-01,
